financetom
Business
financetom
/
Business
/
Insurance broker Brown & Brown Q3 revenue, profit beat estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insurance broker Brown & Brown Q3 revenue, profit beat estimates
Oct 27, 2025 3:29 PM

Overview

* Brown & Brown ( BRO ) Q3 revenue grows 35.4% yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beats consensus, rising 15.4% yr/yr

* Company welcomes over 5,000 new employees in Q3

Outlook

* Company did not provide specific guidance for future quarters or full year in its press release

Result Drivers

* COMMISSIONS AND FEES - Revenue growth driven by a 34.2% increase in commissions and fees

* ORGANIC REVENUE - Organic revenue grew by 3.5%, contributing to overall revenue increase

* NEW EMPLOYEES - Over 5,000 new employees joined, enhancing global capabilities

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $1.61 $1.52

Revenue bln bln (9

Analysts

)

Q3 Beat $1.05 $0.93

Adjusted (12

EPS Analysts

)

Q3 EPS $0.68

Q3 3.5%

Organic

Revenue

Growth

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the multiline insurance & brokers peer group is "buy."

* Wall Street's median 12-month price target for Brown & Brown Inc ( BRO ) is $106.00, about 17.2% above its October 27 closing price of $87.76

* The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 25 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazilian digital lender Nubank invests $150 million in Tyme Group
Brazilian digital lender Nubank invests $150 million in Tyme Group
Dec 16, 2024
SAO PAULO/JOHANNESBURG (Reuters) - Brazilian digital bank Nubank said it has invested $150 million in Tyme Group, a digital bank with 15 million customers in South Africa and the Philippines, funding that will help Tyme Group finance its push into Southeast Asia and list by 2028. In a statement on Monday, Nubank said Tyme Group's series D funding round totalled...
Indivior reshuffles board as CFO exits under Oaktree pressure
Indivior reshuffles board as CFO exits under Oaktree pressure
Dec 17, 2024
Dec 17 (Reuters) - Indivior ( INDV ) said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from No. 2 shareholder Oaktree Capital. The maker of opioid addiction treatment Sublocade has been engaged in conversations with Oaktree Capital Management following the investment fund's repeated calls for the...
Factbox-Scandals that rocked corporate Australia in 2024
Factbox-Scandals that rocked corporate Australia in 2024
Dec 17, 2024
(Reuters) - Australian 'Big-Four' bank ANZ Group's ( ANZGF ) shareholders are set to vote on outgoing chief executive Shayne Elliott's pay this week, while the lender is being investigated for alleged bond-trading misconduct. Australia's corporate regulator pulled up ANZ in May for the alleged breaches that it said occurred last year. The CEO's exit in mid-2025 will mark the...
Drugmaker Indivior's finance chief Preblick to step down
Drugmaker Indivior's finance chief Preblick to step down
Dec 16, 2024
Dec 17 (Reuters) - Indivior ( INDV ) said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from no.2 shareholder Oaktree Capital. The maker of opioid addiction treatment Sublocade also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move...
Copyright 2023-2026 - www.financetom.com All Rights Reserved